IP Library Granted Patent US 8,440,309
Granted Patent B2
US 8,440,309 · App. 13/017,287 · Granted May 14, 2013

Crosslinked polymers with the crosslinker as therapeutic for sustained release

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,309
App. No.
13/017,287
Granted
May 14, 2013
Kind
B2
Abstract

Crosslinked polymers, methods for their preparation and use, are described in which the crosslinked polymers are formed from at least two polymer precursors, one of which is designed, upon degradation of the crosslinked polymer, to release the second polymer precursor in its original, unmodified chemical form.

Claims (11)

1. A polymer precursor comprising a formula

wherein 1≦n≦500,000, and m≧2;

C=represents a core molecule;

R 1 =—H, or an amino acid side chain;

R 2 =an alkyl group; and

R 3 =an electrophilic functional group selected from the group consisting of —CO 2 N(COCH 2 ) 2 , —CO 2 H, —CHO, —CHOCH 2 , —N═C═O, —SO 2 CH═CH 2 , —N(COCH 2 ) 2 , and —S—S—(C 5 H 4 N), or a nucleophilic functional group selected from the group consisting of —NH 2 , —SH, —OH, —PH 2 , and —CO—NH—NH 2 .

2. The polymer precursor of claim 1 , wherein R 1 comprises an amino acid side chain selected from the group consisting of CH 3 , CH 2 —OH, CH 2 —CH(CH 3 ) 2 , CH 2 —CH 2 —CO 2 H, CH 2 —CH 2 —S—CH 3 , CH 2 —SH, CH 2 —CH 2 —CH 2 —CH 2 —NH 2 , CH 2 —CH 2 —CO—NH 2 , CH 2 —CO 2 H, CH 2 —CO—NH 2 , CH(CH 3 ) 2 , C 8 H 6 N 1 —CH 2 , CH(OH)CH 3 , C 6 H 5 —CH 2 , CH 2 —C 6 H 5 —OH, CH 2 —CH 2 —CH 2 —NH—C(NH)(NH 2 ), CH 2 —C 3 H 3 N 2 , (CH 2 ) 2 —CH—OH—CH 2 —NH 2 , CH 2 —(C 6 H 2 I 2 )—(C 6 H 2 I 2 )—OH, CH 2 —(C 3 H 2 N 2 )—CH 3 , CH 2 —CH 2 —CH 2 —CH 2 —NH—CH 3 , CH 2 —CH 2 —CH 2 —CH 2 —N—(CH 3 ) 3 , CH 2 —CH 2 —CH 2 —CO 2 H, CH—(CH 3 )—O—P—(O)(OH) 2 , CH 2 —C 6 H 4 —O—P—(O)(OH) 2 , CH 2 —CH 2 —CH 2 —NH—C—(NH)(NH—CH 3 ), CH 2 —CH 2 —CH 2 —CH 2 —NH—C—(O)(CH 3 ).

3. The polymer precursor of claim 1 , wherein R 1 comprises a natural amino acid side chain not found in proteins selected from the group consisting of CH 2 —CH 2 —OH, CH 2 —CH 2 —SH, CH 2 —O—CO—CH═N═N, CH 2 —S—CH(NH 2 )(CO 2 H), CH(OH)(C 6 H 5 ), C(SH)(CH 3 ) 2 , CH 2 —CH 2 —CH 2 —NH 2 , CH 2 —CH 2 —CH 2 —NH—C(O)(NH 2 ).

4. The polymer precursor of claim 1 , wherein R 2 comprises a C 1 -C 20 alkyl group.

5. The polymer precursor of claim 1 , wherein the core molecule is selected from the group consisting of glycerol, pentaerythritol and sorbitol.

6. The polymer precursor of claim 1 , wherein the core molecule comprises pentaerythritol.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR FROM CONFLUENT SURGICAL, INC. TO COVIDIEN LP AND THE ASSIGNEE FROM COVIDIEN LP TO CONFLUENT SURGICAL, INC. PREVIOUSLY RECORDED ON REEL 031957 FRAME 0239. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT INFORMATION CAN BE FOUND ON THE ASSIGNMENT OF PATENTS DOCUMENT. Recorded Jan 17, 2014
From: COVIDIEN LP
To: CONFLUENT SURGICAL, INC.
Reel/Frame 032086/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2014
From: CONFLUENT SURGICAL, INC.
To: COVIDIEN LP
Reel/Frame 031957/0239 →
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2012
From: BENNETT, STEVEN L.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 028284/0806 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2012
From: CONFLUENT SURGICAL, INC.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 028284/0824 →